상세 보기
초록
Overexpression of Cyclin D2 drives aberrant cell cycle progression in multiple myeloma (MM). However, its lack of intrinsic enzymatic activity renders it an "undruggable" target for conventional small-molecule inhibitors. Here, we report the identification of COT-01, a natural product-derived cortisone analog, as a CRBN-dependent molecular glue degrader of Cyclin D2. COT-01 exhibited CRBN-binding activity with an apparent IC50 of 2.5 mu M in an HTRF-based competitive assay, and BLI analysis independently supported concentration-dependent binding of COT-01 to recombinant human CRBNmidi, with a kinetic KD of 28.6 mu M. COT-01 induced significant G0/G1 phase arrest and apoptosis in MM cells. Targeted proteomic profiling identified Cyclin D2 as one of the most significantly downregulated proteins among those analyzed following COT-01 treatment. Mechanistically, COT01 facilitated the depletion of Cyclin D2 protein levels in a time- and dose-dependent manner without altering its mRNA levels, suggesting a post-translational degradation mechanism. Molecular modeling suggested that the cortisone scaffold of COT-01 engages the ligand-binding pocket of CRBN, while the biochemical and cellular findings support its classification as a molecular glue degrader. Furthermore, in a xenograft mouse model, intraperitoneal administration of COT-01 significantly suppressed tumor growth without significant changes in tumor-free body weight or terminal liver and kidney weights. These findings support further evaluation of COT01 as a CRBN-dependent molecular glue degrader targeting Cyclin D2 in multiple myeloma.
키워드
- 제목
- A natural product-derived degrader (COT-01): cortisone-based CRBN recruitment for cyclin D2 degradation in multiple myeloma
- 저자
- Lee, Seung Hyeong; Kim, Su Ah; Lee, Kyeong Eun; Lim, Yewon; Ahn, Hyo Jung; Kim, Doyoun; Jang, Woo Dae; Lim, Hwan Jung; Lee, Jeong Hyun; Oh, Kwang-Seok
- 발행일
- 2026-11-05
- 유형
- Article
- 권
- 183
- 언어
- ENG
- 출판사
- ACADEMIC PRESS INC ELSEVIER SCIENCE
- 발행국가
- 미국
- ISSN
- E 1090-2120
P 0045-2068